U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3708137081Distribution of Fortified Yoghurt in Senegal to Decrease Children's Anemia and Improve Milk SupplyCompletedNo Results AvailableAnemia|Iron-DeficiencyDietary Supplement: Micronutrient-fortified yoghurt|Behavioral: BCChttps://ClinicalTrials.gov/show/NCT02079961
3708237082Inflammation Control For Elders: ICE StudyTerminatedNo Results AvailableInflammation|AgingDrug: Methotrexate + Folic Acid|Drug: Placebo + Folic Acid|Procedure: Functional MRI Experimental Tasks|Procedure: Muscle Biopsyhttps://ClinicalTrials.gov/show/NCT02079948
3708337083Treatment of Eating Disorders by Physical Activity and Nutrition CounselingRecruitingNo Results AvailableBulimia Nervosa|Binge Eating DisorderBehavioral: Cognitive Behaviour Therapy|Behavioral: Physical Activityhttps://ClinicalTrials.gov/show/NCT02079935
3708437084A Multiple Dose Study Of PF-06678552 In Healthy SubjectsCompletedNo Results AvailableHealthyDrug: PF-06678552|Drug: Placebo|Drug: PF-06678552|Drug: Placebo|Drug: PF-06678552|Drug: Placebo|Drug: PF-06678552|Drug: Placebo|Drug: PF-06678552|Drug: Placebo|Drug: PF-06678552|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02079922
3708537085Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)RecruitingNo Results AvailableAlzheimer's DiseaseDrug: T-817MAhttps://ClinicalTrials.gov/show/NCT02079909
3708637086Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis PatientsRecruitingNo Results AvailableAnemia|End Stage Renal DiseaseDrug: Lexaptepid pegol (NOX-H94)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02079896
3708737087Ocriplasmin Research to Better Inform Treatment (ORBIT)RecruitingNo Results AvailableSymptomatic Vitreomacular Adhesionhttps://ClinicalTrials.gov/show/NCT02079883
3708837088Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With PlaceboCompletedNo Results AvailableHealthy|Diabetes|ObesityDrug: semaglutide|Drug: placebohttps://ClinicalTrials.gov/show/NCT02079870
3708937089Symptom Management for Irritable Bowel SyndromeRecruitingNo Results AvailableIrritable Bowel SyndromeOther: Standard protocol|Other: Individualized protocol|Other: Sham acupuncture/Placebo moxahttps://ClinicalTrials.gov/show/NCT02079857
3709037090Roflumilast Plus Antipsychotics Proof of Mechanism Study in SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Roflumilast|Drug: Placebo|Drug: Second generation antipsychotichttps://ClinicalTrials.gov/show/NCT02079844
3709137091PrOtein and WEight Loss in teenageRsCompletedNo Results AvailablePediatric ObesityBehavioral: Energy Restriction|Behavioral: Higher protein|Behavioral: Lower Proteinhttps://ClinicalTrials.gov/show/NCT02079831
3709237092Visceral Artery Aneurysm Embolization by the Penumbra Rubyâ„¢ Coil SystemNot yet recruitingNo Results AvailableVisceral Artery Aneurysms|Arteriovenous MalformationsDevice: Penumbra Ruby Coil Systemhttps://ClinicalTrials.gov/show/NCT02079818
3709337093A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RRecruitingNo Results AvailableEssential Hypertension Complicated by Type 2 Diabetes MellitusDrug: Azilsartan|Drug: Telmisartanhttps://ClinicalTrials.gov/show/NCT02079805
3709437094The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization DeviceRecruitingNo Results AvailableSinusitisProcedure: Lying Head Back Position|Procedure: Head Down and Forward Positionhttps://ClinicalTrials.gov/show/NCT02079792
3709537095Efficacy Study of an Interactive Robot for the Rehabilitation of the Upper Limb in Acute Stroke PatientsRecruitingNo Results AvailableAcute StrokeOther: Robotic-assisted therapy|Other: Classical therapyhttps://ClinicalTrials.gov/show/NCT02079779
370963709618F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects at Risk for Chronic Traumatic EncephalopathyRecruitingNo Results AvailableChronic Traumatic EncephalopathyDrug: florbetapir F 18|Drug: 18F-AV-1451https://ClinicalTrials.gov/show/NCT02079766
3709737097Single Portable Pulse-dose-conserving Device vs. Combined Use of Stationary and Portable.CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDevice: Inogen|Device: Combination system of a portable and a stationary device.https://ClinicalTrials.gov/show/NCT02079753
3709837098Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid TumorsRecruitingNo Results AvailableAdult Solid Neoplasm|Extensive Stage Small Cell Lung Carcinoma|Recurrent Colon Carcinoma|Recurrent Non-Small Cell Lung Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Rectal Carcinoma|Recurrent Small Cell Lung Carcinoma|Stage III Pancreatic Cancer|StagOther: Laboratory Biomarker Analysis|Biological: Navitoclax|Other: Pharmacological Study|Drug: Trametinibhttps://ClinicalTrials.gov/show/NCT02079740
3709937099Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OAActive, not recruitingNo Results AvailableKnee OsteoarthritisDrug: chondroitin sulfate|Drug: celecoxib|Drug: placebohttps://ClinicalTrials.gov/show/NCT02079727
3710037100Streamlining Trauma Research Evaluation With Advanced MeasurementRecruitingNo Results AvailableOrthopaedic Traumahttps://ClinicalTrials.gov/show/NCT02079714
3710137101Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military RecruitsCompletedNo Results AvailablePneumonia|Acute Respiratory DiseaseBiological: 23-valent pneumococcal vaccine|Biological: Placebohttps://ClinicalTrials.gov/show/NCT02079701
3710237102Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic EczemaRecruitingNo Results AvailableMild to Moderate Atopic DermatitisDrug: SB011, 2 % (Water/Oil/Water) emulsion of hgd40|Drug: Multiple W/O/W formulation, active ingredient-free vehiclehttps://ClinicalTrials.gov/show/NCT02079688
3710337103Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel SyndromeCompletedNo Results AvailableNon-constipation Irritable Bowel SyndromeDrug: SKI3246 Low Dose|Drug: SKI3246 High Dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02079675
3710437104The Role of Lifestyle Factors in Breast Cancer-Related OutcomesRecruitingNo Results AvailableBreast CancerBehavioral: Aerobic Activity|Behavioral: Dietician Counseling|Behavioral: Yoga|Behavioral: Cognitive Behavior Therapy|Behavioral: Smoking Cessation Counseling|Behavioral: Questionnaires|Other: Saliva Samples|Behavioral: Dietary Assessment|Procedure: Blood Sampleshttps://ClinicalTrials.gov/show/NCT02079662
3710537105Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic ConjunctivitisCompletedHas ResultsAllergic ConjunctivitisDrug: AL-53817 Ophthalmic Solution, 0.1%|Drug: AL-78843 Ophthalmic Solution, 0.03%|Drug: Dexamethasone Ophthalmic Suspension, 0.1%|Drug: AL-53817 Vehiclehttps://ClinicalTrials.gov/show/NCT02079649
3710637106A Study of LY2835219 in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)RecruitingNo Results AvailableCarcinoma, Non-small Cell LungDrug: LY2835219|Drug: Pemetrexed|Drug: Gemcitabine|Drug: Ramucirumab|Drug: LY3023414https://ClinicalTrials.gov/show/NCT02079636
3710737107Electroporation (NanoKnife) as Treatment for Advanced Pancreatic CancerEnrolling by invitationNo Results AvailablePancreatic CancerProcedure: Electroporation/ Nano knife treatment|Device: NanoKnifehttps://ClinicalTrials.gov/show/NCT02079623
3710837108Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing BiasesRecruitingNo Results AvailableMajor Depressive DisorderBehavioral: real-time fMRI neurofeedback: Amygdala|Behavioral: real-time fMRI neurofeedback: HIPShttps://ClinicalTrials.gov/show/NCT02079610
3710937109The Role of Ninjurin-1 During Systemic InflammationCompletedNo Results AvailableNinj1 Expression|SIRShttps://ClinicalTrials.gov/show/NCT02079597
3711037110Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific AnticoagulantRecruitingNo Results AvailableVenous Thromboembolismhttps://ClinicalTrials.gov/show/NCT02079584

* Görseller ve İçerik tekif hakkına sahip olabilir